ATE121631T1 - Wässrige suspension als injektionszubereitung, verfahren zur herstellung derselben und verwendung für schmerzstillung. - Google Patents

Wässrige suspension als injektionszubereitung, verfahren zur herstellung derselben und verwendung für schmerzstillung.

Info

Publication number
ATE121631T1
ATE121631T1 AT91906827T AT91906827T ATE121631T1 AT E121631 T1 ATE121631 T1 AT E121631T1 AT 91906827 T AT91906827 T AT 91906827T AT 91906827 T AT91906827 T AT 91906827T AT E121631 T1 ATE121631 T1 AT E121631T1
Authority
AT
Austria
Prior art keywords
preparation
less
pain relief
injection
aqueous suspension
Prior art date
Application number
AT91906827T
Other languages
English (en)
Inventor
Eric Willem Ackerman
Rene Jacobus Elisabeth Grouls
Hendrikus Hubertus Mar Korsten
Original Assignee
Catharina Ziekenhuis Stichting
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catharina Ziekenhuis Stichting filed Critical Catharina Ziekenhuis Stichting
Application granted granted Critical
Publication of ATE121631T1 publication Critical patent/ATE121631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT91906827T 1990-03-20 1991-03-20 Wässrige suspension als injektionszubereitung, verfahren zur herstellung derselben und verwendung für schmerzstillung. ATE121631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9000634A NL9000634A (nl) 1990-03-20 1990-03-20 Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.

Publications (1)

Publication Number Publication Date
ATE121631T1 true ATE121631T1 (de) 1995-05-15

Family

ID=19856770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906827T ATE121631T1 (de) 1990-03-20 1991-03-20 Wässrige suspension als injektionszubereitung, verfahren zur herstellung derselben und verwendung für schmerzstillung.

Country Status (15)

Country Link
US (1) US5346903A (de)
EP (1) EP0521070B1 (de)
JP (1) JPH05507466A (de)
AT (1) ATE121631T1 (de)
AU (1) AU646857B2 (de)
BR (1) BR1100601A (de)
CA (1) CA2077641C (de)
DE (1) DE69109279T2 (de)
DK (1) DK0521070T3 (de)
ES (1) ES2074269T3 (de)
FI (1) FI98890C (de)
GR (1) GR3015940T3 (de)
NL (1) NL9000634A (de)
NO (1) NO300114B1 (de)
WO (1) WO1991014455A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
EA001257B1 (ru) * 1996-03-26 2000-12-25 Эли Лилли Энд Компани Бензотиофены, содержащие их фармацевтические композиции и способы лечения патологических состояний с их использованием
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
EP1389121B1 (de) 2001-04-24 2012-02-22 Purdue Research Foundation Verfahren und zusammensetzungen zur behandlung von nervengewebeverletzungen in säugetieren
US20030181426A1 (en) * 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
US7838034B2 (en) 2002-07-30 2010-11-23 Grunenthal Gmbh Intravenous pharmaceutical form of administration
DE10234784A1 (de) * 2002-07-30 2004-02-19 Günenthal GmbH Intravenös applizierbare, pharmazeutische Darreichungsform
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
RU2357750C2 (ru) * 2002-12-31 2009-06-10 Элтус Фармасьютикалз Инк. Кристаллы человеческого гормона роста и способы их получения
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
CA2672284C (en) * 2006-12-18 2014-08-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
FI20075091A0 (fi) * 2007-02-09 2007-02-09 Kim Lemberg Noroksimorfoni käytettäväksi lääkeaineena
WO2008106571A2 (en) * 2007-02-28 2008-09-04 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US9125867B2 (en) * 2010-02-24 2015-09-08 Invincible Biotechnology Diversion- and/or abuse-resistant compositions and methods for making the same
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CA3015557C (en) 2014-11-07 2019-07-16 Indivior Uk Limited The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
WO2021073548A1 (zh) * 2019-10-16 2021-04-22 广东东阳光药业有限公司 一种药物组合物
WO2022175977A1 (en) * 2021-02-18 2022-08-25 Navin Saxena Research And Technology Private Limited A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US3337406A (en) * 1963-12-12 1967-08-22 Mar Sal Inc Treatment of arteriosclerotic diseases
EP0031603A1 (de) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmazeutische Zusammensetzung eines Grundstoffs
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief

Also Published As

Publication number Publication date
CA2077641A1 (en) 1991-09-21
JPH05507466A (ja) 1993-10-28
NL9000634A (nl) 1991-10-16
WO1991014455A1 (en) 1991-10-03
ES2074269T3 (es) 1995-09-01
CA2077641C (en) 2001-07-03
FI924019L (fi) 1992-09-08
NO923429L (no) 1992-09-17
BR1100601A (pt) 2000-04-18
US5346903A (en) 1994-09-13
EP0521070B1 (de) 1995-04-26
GR3015940T3 (en) 1995-07-31
DE69109279T2 (de) 1995-11-09
FI98890B (fi) 1997-05-30
FI924019A0 (fi) 1992-09-08
AU7558091A (en) 1991-10-21
AU646857B2 (en) 1994-03-10
NO300114B1 (no) 1997-04-14
DE69109279D1 (de) 1995-06-01
FI98890C (fi) 1997-09-10
EP0521070A1 (de) 1993-01-07
DK0521070T3 (da) 1995-05-22
NO923429D0 (no) 1992-09-03

Similar Documents

Publication Publication Date Title
ATE121631T1 (de) Wässrige suspension als injektionszubereitung, verfahren zur herstellung derselben und verwendung für schmerzstillung.
ATE149828T1 (de) Arzneistofformulierung zur parenteralen anwendung
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
DE59502704D1 (de) Aerogelhaltige zusammensetzung, verfahren zur ihrer herstellung sowie ihre verwendung
JPS55147228A (en) Fat emulsion for intravenous injection
ZA959386B (en) Small particle formation
IL109904A0 (en) Secondary amines as antidiabetic and antiobesity agents
DE59209244D1 (de) Inhalationspulver und verfahren zu ihrer herstellung
ATE206067T1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
KR970704438A (ko) 티아졸 및 티아디아졸 화합물의 D 도파민 수용체 리간드로서의 용도(Use of Thiazole and Thiadiazole Compounds as D Dopamine Receptor Ligands)
Jaurand et al. Effect of chrysotile and crocidolite on the morphology and growth of rat pleural mesothelial cells
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
KR900007319A (ko) 살충 조성물
Lovell et al. Muscle spindles in nonhuman primate extrinsic auricular muscles
EP0135189A3 (de) Pharmazeutisch verwendbare Malonamide
Rose The effect of cortin and desoxycorticosterone acetate on the ability of the adrenalectomized rat to inactivate histamine
ATE218510T1 (de) Verfahren zur herstellung eines titansilikates mit rut-struktur
EP0276466A3 (de) Aminoazolderivate, Verfahren zu deren Herstellung und deren Verwendung als antimykotische Mittel
EP0338793A3 (de) Antihypertensive Sulfonanilide
ATE106413T1 (de) Verfahren zur herstellung eines feinteiligen vinylchlorid-pfropfcopolymerisats.
DE69228815D1 (de) Schmierölzusammensetzung, verfahren zur herstellung und verwendungen davon, besonders als ölzusatz
Kretz et al. Differentialindikation von Halothan, Enfluran und Isofluran in der Kinderanästhesie
Ishikawa Growth and mitotic activity of lung colonies derived from mouse teratocarcinomas
Leonov et al. Protective effect of serotonin against the inhibitory action of chlorpromazine on membrane potential of two-blastomere mouse embryos in vitro
AU635948B2 (en) Liquid suspensions of nitrofurantoin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee